Table 1

Clinical, haemodynamic and hormonal characteristics of the three group patients

Group 1 (n  =  88)Group 2 (n  =  9)Group 3 (n  =  9)p Value
Data are mean (SD).
*p < 0.05, **p  =  0.09 group 3 versus group 2 by analysis of variance.
A, late diastolic wave velocity; E, early diastolic wave velocity; LV, left ventricular; NS, not significant; NYHA, New York Heart Association functional class; V̇e−V̇co2, minute ventilation-carbon dioxide production; V̇o2, oxygen uptake.
Age (years)61 (9)65 (4)66 (6)NS
NYHA III-IV32%66%44%NS
Noradrenaline (pg/ml)392 (263)534 (402)510 (258)NS
Adrenaline (pg/ml)53 (36)50 (28)44 (18)NS
Aldosterone (nmol/l)0.25 (0.1)0.29 (0.1)0.24 (0.1)NS
K (mmol/l)4.3 (0.4)4.2 (0.3)4.4 (0.3)NS
Na (mmol/l)139 (3)138 (2)138 (3)NS
Creatinine (μmol/l)101 (27)86 (35)99 (15)NS
Peak V̇o2 (ml/kg/min)18 (5)13 (5)14 (3)0.01
e−V̇co2 slope36 (6)43 (7)45 (11)0.0002
Duration of exercise (min)10 (2.0)8.3 (2.5)8.5 (2.2)0.02
Respiratory exchange ratio1.1 (0.1)1.1 (0.1)1.1 (0.1)NS
LV mass (g)224 (49)253 (16)212 (63)NS
Mass to volume ratio0.94 (0.3)0.84 (0.1)0.68 (0.2)0.01
Stroke volume (ml)82 (17)67 (17)58 (14)*0.02
LV end diastolic volume (ml)253 (59)329 (93)325 (112)0.01
LV end systolic volume (ml)163 (53)239 (91)247 (98)0.002
LV ejection fraction (%)36 (6)29 (8)25 (6)**0.0001
Mitral regurgitant volume (ml)12 (15)23 (17)19 (19)NS
Left atrial maximum volume (ml)101 (39)117 (47)123 (25)NS
Left atrial minimum volume (ml)53 (25)77 (38)94 (26)0.0006
Left atrial ejection fraction (%)0.47 (0.1)0.43 (0.2)0.26 (0.1)*<0.0001
E (m/s)0.6 (0.1)0.8 (0.1)0.9 (0.1)0.0007
E:A0.9 (0.3)1.6 (0.6)2.2 (0.9)*<0.0001
E wave deceleration time (ms)233 (73)136 (19)119 (5)0.0001